52 Biggest Movers From Friday
Gainers
Splash Beverage Group, Inc. (NASDAQ: SBEV) shares gained 118.9% to settle at $4.18 on Friday. Splash Beverage recently announced it has received authorization to sell its TapouT performance drink in Walmart stores across Florida metropolitan areas.
Molecular Partners Finalized License Agreement with Novartis for Ensovibep for COVID-19; Molecular Partners to Receive Milestone Payment of CHF150M, 22% Royalty on Ensovibep Sales in Relevant Territories
Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, today announced that Molecular Partners and Novartis have entered into a license agreement under which Novartis will in-license global rights to ensovibep from Molecular Partners.
The Week Ahead In Biotech (Jan 16-22): Focus On Data Presentations And IPOs In Holiday-Shortened Week
Biotech stocks posted losses for the third straight week, as the sector reacted to broader market weakness and announcements out of the 2022 JPMorgan Healthcare conference.
Mid-Day Market Update: Crude Oil Rises Over 1%; FTC Solar Shares Slide
Midway through trading Friday, the Dow traded down 0.78% to 35,833.47 while the NASDAQ fell 0.12% to 14,789.14. The S&P also fell, dropping, 0.41% to 4,640.11.
18 Stocks Moving in Friday’s Pre-Market Session
Gainers
Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) shares rose 17.6% to $0.8350 in pre-market trading after dropping around 9% on Thursday.
SVB Leerink Maintains Outperform on Molecular Partners, Raises Price Target to $42
SVB Leerink analyst Daina Graybosch maintains Molecular Partners (NASDAQ:MOLN) with a Outperform and raises the price target from $35 to $42.
48 Biggest Movers From Yesterday
Gainers
Splash Beverage Group, Inc. (NYSE: SBEV) shares jumped 70.6% to close at $1.80 on Tuesday after the company announced it received authorization to sell its TapouT performance drink in Walmart stores across Florida metropolitan areas.